Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Long-Term Investments (2017 - 2026)

Bioceres Crop Solutions' Long-Term Investments history spans 10 years, with the latest figure at $40.6 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments changed N/A to $40.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $40.6 million, a N/A change, with the full-year FY2025 number at $39.4 million, down 0.97% from a year prior.
  • Long-Term Investments hit $40.6 million in Q1 2026 for Bioceres Crop Solutions, up from $39.4 million in the prior quarter.
  • Over the last five years, Long-Term Investments for BIOX hit a ceiling of $40.6 million in Q1 2026 and a floor of $38.6 million in Q2 2022.
  • Historically, Long-Term Investments has averaged $39.5 million across 5 years, with a median of $39.4 million in 2025.
  • Biggest five-year swings in Long-Term Investments: grew 25.76% in 2022 and later decreased 0.97% in 2025.
  • Tracing BIOX's Long-Term Investments over 5 years: stood at $38.6 million in 2022, then increased by 1.93% to $39.3 million in 2023, then rose by 1.25% to $39.8 million in 2024, then fell by 0.97% to $39.4 million in 2025, then grew by 3.05% to $40.6 million in 2026.
  • Business Quant data shows Long-Term Investments for BIOX at $40.6 million in Q1 2026, $39.4 million in Q2 2025, and $39.8 million in Q2 2024.